Article
Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.
Genome - 1 May 2014
Motawi Tarek M K, Shaker Olfat G, El-Sawalhi Maha M, Abdel-Nasser Zeinab M
Abstract excerpt
Diabetes mellitus is one of the main threats to human health in the 21st century. Visfatin/Nampt and resistin are novel adipokines that have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) complication. Several genetic studies have shown inconsistent results regarding association of visfatin/Nampt gene (NAMPT) and resistin gene (RETN) polymorphisms with T2DM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
